Dr. Tavana is awarded a new grant from Ohio Third Frontier as Technology Validation and Start-up Fund to evaluate the feasibility of our tumor spheroid microtechnology for commercialization.
Media coverage of our research
Our tumor spheroid microtechnology and funding through NIH is highlighted by local NPR channel!
Presentation at Regenerative Medicine meeting
Ehsan presented his research at the National Center for Regenerative Medicine (NCRM) and won the first place poster presentation!
New PhD student
The lab welcomes Ramila Joshi as a new PhD student!
Media coverage of our cancer technology
Ehsan’s and Stephanie’s projects on developing a cancer microtechnology for drug screening is highlighted on various science news websites: http://phys.org/wire-news/144680208/akron-researcher-awarded-nih-grant-for-advancing-3-d-tumor-model.html http://www.eurekalert.org/pub_releases/2013-10/uoa-ara103113.php http://news.cell.com/story.php?title=akron-researcher-awarded-nih-grant-for-advancing-3-d-tumor-models-for-anticancer-drug-testing
Biotechnology Journal paper
Stephanie’s paper on a cell migration technology is accepted for publication in Biotechnology Journal!
Media coverage of our NIH Funding
Our new NIH R21 funding is highlighted on main page of The University of Akron.
Technology commercialization grant to Dr. Tavana
Our lab was awarded a grant through NSF I-Corps Sites program and selected to participate in a technology commercialization course at UA!
Presentations at BMES
Dr. Tavana gave a talk and Stephanie and Ehsan presented three posters at BMES 2013 in Seattle.
NIH grant to Dr. Tavana
Dr. Tavana was awarded another federal grant! Through this award by the National Cancer Institute of NIH (R21 CA182333), our lab will develop a microtechnology for high throughput generation of […]